Sawyer Howitt Moves Up The Ranks In Racquetball

In the game of racquetball, Sawyer Howitt is working hard as he attempts to make a name for himself. Howitt — who attended Lincoln High School in Portland, Oregon — began his career in the sport while playing for his high school team. In 2015, Howitt and his teammates competed for the Oregon High School Racquetball State Championships. He won some matches and lost some matches along the way.

Outside of high school, Howitt now participates with the Racquet Club of Portland and he is playing in matches. He is beginning to rise in the sport and he could be the next superstar in it.


A Closer Look at WEN Cleansing Conditioners

WEN is a very popular brand of hair care products. At the very core, WEN works to simplify hair care, as well as remove some of the potentially harmful sulfates that a lot of common shampoo products may contain. The company produces all of its products at the highest standards for customer satisfaction.

No animal testing is performed in the production of the WEN hair care products. The company also offers a sixty day money back guarantee. Customers are able to return their purchases if they find them unsatisfactory, even if their container has already been emptied.

WEN Cleansing Conditioners (@wenhaircare) allow users to get the benefits of five different hair care products, all in one. The cleansing conditioners cut out the need for shampoo, conditioner, deep conditioner, detangler and leave in conditioner. A few different formulas are available for use, including sweet almond mint and pomegranate.

Related: 7 Best Wen Products — and the 2 Worst

The company boasts that WEN Cleansing Conditioners are the perfect solution for all types of hair, helping moisturize and strengthen without the harsh sulfates or unnecessary lather of many other brands of shampoo. The formula contains all natural ingredients that help hydrated and clean, without stripping hair of essential, natural oil. The effect is noticeably healthy-looking clean hair.

Click here to learn more about WEN creator Chaz Dean.

 


Seattle Genetics Boss, Clay Siegall, to Join Mirna Therapeutics Inc.’s Board

In 2013, Mirna Therapeutics announced that its new outside board member will be Clay Siegall Ph.D. Siegall currently serves as the CEO, President, and board Chairman of Seattle Genetics. Mirna Therapeutics is a privately-held company that was established in 2007 and is located in Austin, Texas. It concentrates on the development of microRNA in therapeutics.

Currently, the company has focused its attention on cancer research, an area that Clay Siegall has a ton of experience in. The CEO and President of Mirna Therapeutics, Dr. Paul Lammers, reiterated that the company was thrilled to welcome Siegall and looked forward to picking his brain on several areas relevant to their research especially their microRNA therapeutics.

Seattle Genetics

Seattle Genetics is a prominent biotechnology company that primarily develops clinical products. Founded in 1998, the company has come a long way from its inception to the development of its latest cutting edge innovation, the antibody-drug conjugate (ADC). The company’s headquarters are found in Bothell Washington. The company has partnered with several leading organizations including Curagen, Medimmune, Genentech and Bayer Pharmaceuticals.

Clay Siegall Ph.D.

Clay Siegall is one of the co-founders of Seattle Genetics. Today, he is the CEO of the company. He also chairs the board of directors. The highly accomplished scientist has dedicated his life in the development of targeted cancer therapies that are needed in the research, treatment, and cure of cancer. He has maintained a foundation of rigorous research, drug development practices, and scientific innovation within Seattle Genetics.

Clay Siegall has guided Seattle Genetics’ capital raising activities. To date, the company has secured over $675 million in private and public financing thanks to the networking efforts of Clay Siegall. He led the initial public offering (IPO) of the company in 2001. Siegall has a Genetics Ph.D. from George Washington University. He also holds a Bachelor of Science in Zoology studies from the acclaimed University of Maryland.

Siegall has been instrumental in the development and deployment of antibody-drug conjugates (ADCs) currently used in the treatment of cancer. To date, he is a published author whose is accredited with over 70 publications. He also holds an incredible 15 patents to his name.

Continue Reading:

http://newschoolmagazine.com/index.php/category/clay-siegall/